1. Home
  2. LTRN vs ONMD Comparison

LTRN vs ONMD Comparison

Compare LTRN & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$2.15

Market Cap

22.2M

Sector

Health Care

ML Signal

HOLD

Logo OneMedNet Corp

ONMD

OneMedNet Corp

HOLD

Current Price

$1.00

Market Cap

45.8M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRN
ONMD
Founded
2013
2006
Country
United States
United States
Employees
N/A
23
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.2M
45.8M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LTRN
ONMD
Price
$2.15
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
315.7K
861.7K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
18.65
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$0.31
52 Week High
$5.74
$4.22

Technical Indicators

Market Signals
Indicator
LTRN
ONMD
Relative Strength Index (RSI) 45.48 54.29
Support Level $1.11 $0.92
Resistance Level $2.41 $1.14
Average True Range (ATR) 0.32 0.11
MACD -0.03 0.01
Stochastic Oscillator 15.12 35.65

Price Performance

Historical Comparison
LTRN
ONMD

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.

Share on Social Networks: